Загрузка...
Grading of neurological toxicity in patients treated with tisagenlecleucel in the JULIET trial
Chimeric antigen receptor-T (CAR-T) cell therapy achieves durable responses in patients with relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL), but may be associated with neurological toxicity (NT). We retrospectively assessed differences and concordance among 3 available grading scales...
Сохранить в:
| Опубликовано в: : | Blood Adv |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society of Hematology
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7160265/ https://ncbi.nlm.nih.gov/pubmed/32271898 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019001305 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|